Company Profile
Updated: 26-OCT-09OSI Pharmaceuticals Inc.
Public Company, Headquarters Location
41 Pinelawn Rd., Melville, NY 11747-3149, United States
(631)962-2000, (631)752-3880 fax, http://www.osip.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Research and development of pharmaceutical drugs for diseases including cancer, atherosclerosis, neurological disorders and chronic anemias.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
OSI Pharmaceuticals Sets R&D Analyst Day Webcast
Wireless News; 12/7/2009; 309 words; ...Wireless News 12-07-2009 OSI Pharmaceuticals Sets R&D Analyst...NewsOSI Pharmaceuticals, Inc. has announced that it...Officer, and members of OSI's management team...2009 Close-Up Media, Inc. All Rights Reserved...
FORM 8-K: OSI PHARMACEUTICALS ANNOUNCES OTHER EVENTS
US Fed News Service, Including US State News; 12/5/2009; 1065 words; WASHINGTON, Dec. 4 -- OSI PHARMACEUTICALS, INC., Melville, N.Y., files Form 8-K (current...of registrant as specified in its charter is OSI PHARMACEUTICALS, INC. Other Events On December 3, 2009, Colin Goddard...
Conference Calls Today: 12:30-2:20 P.M. EDT.
Investrend; 12/3/2009; 917 words; ...today at 12:30 to 2:20 p.m. include: OSI Pharmaceuticals Inc. (NASDAQ: OSIP), Watts Water Technologies Inc. (NYSE: WTS), Toll Brothers Inc. (NYSE: TOL), Sprint Nextel Corporation...
OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer.
Cancer Weekly; 12/1/2009; 1289 words; ...the treatment of cancer (see also OSI Pharmaceuticals, Inc.). In June 2009, the FDA accepted...Non-Small Cell Lung Carcinoma, OSI Pharmaceuticals Inc., Oncology, Pancreas, Pharmaceutical, Pharmaceutical Business, Pharmaceutical...
NewCo News: Scripps Spinout Xcovery Sees Room for Kinase Improvement.
BIOWORLD Today; 12/1/2009; 1117 words; ...about a third of all pharmaceutical discovery efforts...and CEO of Xcovery Inc., would argue the...sorafenib, Onyx Pharmaceuticals Inc. and Bayer AG...sunitinib, Pfizer Inc.), Tarceva (erlotinib, OSI Pharmaceuticals Inc...
Recent News Articles
- OSI Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results.(Financial report)
Biotech Week - November 04, 2009 - Sign Up For Free Newsletter!!! Todays Picks Are (OTCBB: FORC) Force Energy Corp. (NASDAQ: OSIP) OSI Pharmaceuticals, Inc. (NASDAQ: OSIS) OSI Systems, Inc. (NASDAQ: OUTD) Outdoor Channel Holdings, Inc. (NASDAQ: OXGN) OXiGENE, Inc. (NASDAQ: PARL) Parlux Fragrances, Inc.
M2 Presswire - October 13, 2009 - News and FDA Updates for Lannett Company (NYSE:LCI), OSI Pharmaceuticals, Inc. (NASDAQ:OSIP).
M2 Presswire - September 09, 2009 - Schaeffer's Tool Box: OSI Pharmaceuticals Inc. and Leap Wireless International.
Business Wire - August 19, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning